Unused files

The following files exist but are not embedded in any page. Please note that other websites may link to a file with a direct URL, and so may still be listed here despite being in active use.

Showing below up to 50 results in range #19,721 to #19,770.

• 
  Nafcillin ingredients and appearance.png 635 × 2,152; 203 KB
  
• 
  Carmustine structure.png 265 × 247; 16 KB
  
• 
  Carmustine 100 mg.png 525 × 206; 145 KB
  
• 
  Bosutinib07.png 659 × 334; 124 KB
  
• 
  Bosutinib08.png 648 × 336; 124 KB
  
• 
  Bosutinib09.png 629 × 3,081; 190 KB
  
• 
  Cevimeline adverse effects table 01.png 852 × 614; 140 KB
  
• 
  Cevimeline adverse effects table 02.png 664 × 774; 148 KB
  
• 
  Golimumab 100 mg-ml.png 641 × 593; 489 KB
  
• 
  Golimumab 50 mg-0.5 ml.png 632 × 583; 427 KB
  
• 
  Prilocaine hcl.jpg 970 × 1,082; 151 KB
  
• 
  Prilocaine ingredients and appearance.png 648 × 1,146; 101 KB
  
• 
  Oxacillin 01.png 314 × 152; 25 KB
  
• 
  Ox02.jpg 824 × 224; 95 KB
  
• 
  Ox03.jpg 824 × 224; 95 KB
  
• 
  DailyMed - OXACILLIN- oxacillin sodium injection, solution .png 610 × 2,334; 209 KB
  
• 
  DailyMed - D.H.E. 45- dihydroergotamine mesylate injection, solution .png 615 × 866; 69 KB
  
• 
  Uno1.jpg 1,926 × 2,440; 570 KB
  
• 
  DailyMed - UNDECYLENIC ACID - undecylenic acid liquid .png 622 × 1,200; 98 KB
  
• 
  Undecylenic acid.png 748 × 150; 4 KB
  
• 
  DailyMed - CYSTEX PLUS- methenamine and sodium salicylate tablet .png 622 × 1,677; 146 KB
  
• 
  M&S 01.jpg 1,241 × 1,730; 414 KB
  
• 
  G 01.jpg 249 × 474; 48 KB
  
• 
  G02.jpg 985 × 1,186; 210 KB
  
• 
  G03.jpg 249 × 699; 60 KB
  
• 
  G04.jpg 984 × 1,185; 221 KB
  
• 
  G05.jpg 249 × 474; 48 KB
  
• 
  G06.jpg 968 × 520; 117 KB
  
• 
  Ingredients.png 620 × 2,362; 194 KB
  
• 
  Daliresp fig.jpg 998 × 469; 121 KB
  
• 
  Daliresp fig01.jpg 1,000 × 866; 113 KB
  
• 
  Roflumilast image.jpg 1,000 × 866; 113 KB
  
• 
  Votrient image.jpg 802 × 404; 76 KB
  
• 
  Empagliflozin PK Figure 2.png 630 × 627; 246 KB
  
• 
  Trametinib dimethyl sulfoxide Chemical structure.png 224 × 158; 13 KB
  
• 
  Trametinib dimethyl sulfoxide Selected Adverse Reactions Occurring in ≥10%.png 623 × 1,127; 105 KB
  
• 
  Trametinib dimethyl sulfoxide Percent-Patient Incidence of Laboratory Abnormalities Occurring at a Higher Incidence.png 624 × 541; 51 KB
  
• 
  Trametinib dimethyl sulfoxide Common Adverse Drug Reactions.png 629 × 2,696; 226 KB
  
• 
  Trametinib dimethyl sulfoxide Treatment-Emergent Laboratory Abnormalities.png 639 × 1,501; 120 KB
  
• 
  Trametinib dimethyl sulfoxide 0.5 mg FDA package label.png 620 × 1,225; 110 KB
  
• 
  Trametinib dimethyl sulfoxide 2 mg FDA package label.png 627 × 1,352; 117 KB
  
• 
  Trametinib dimethyl sulfoxide 1 mg FDA package label.png 621 × 1,201; 107 KB
  
• 
  Trametinib dimethyl sulfoxide BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic Melanoma (1).png 631 × 1,386; 141 KB
  
• 
  Trametinib dimethyl sulfoxide BRAF V600E or V600K Mutation-Positive Unresectable or Metastatic Melanoma (2).png 622 × 889; 79 KB
  
• 
  Trametinib dimethyl sulfoxide 0.5 mg.png 638 × 217; 151 KB
  
• 
  Trametinib dimethyl sulfoxide 1 mg.png 639 × 215; 153 KB
  
• 
  Trametinib dimethyl sulfoxide 2 mg.png 635 × 215; 148 KB
  
• 
  Trametinib dimethyl sulfoxide structure.png 263 × 130; 6 KB
  
• 
  Anakinra09.png 628 × 797; 339 KB
  
• 
  Anakinra10.png 607 × 1,401; 83 KB